Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

详细信息    查看全文

• 作者：Nirmitha I Herath (1)
  Mark D Spanevello (1)
  Sabe Sabesan (1)
  Tanya Newton (2)
  Margaret Cummings (4)
  Shannon Duffy (1)
  Douglas Lincoln (3)
  Glen Boyle (2)
  Peter G Parsons (2)
  Andrew W Boyd (1) (4)
  
• 刊名：BMC Cancer
• 出版年：2006
• 出版时间：December 2006
• 年：2006
• 卷：6
• 期：1
• 全文大小：577KB
• 参考文献：1. Boyd AW, Lackmann M: plus-plus">Signals from Eph and ephrin proteins: a developmental tool kit. / Sci STKE 2001., plus-plus">RE20:
  2. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DJ, Pawson T, Davis S, Yancoupoulos GD: plus-plus">Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalised during embryogenesis. / Neuron 1996, plus-plus">17: 9鈥?9. p://dx.doi.org/10.1016/S0896-6273(00)80276-7">CrossRef
  3. Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF, Boyd AW: plus-plus">The role of the Eph-ephrin signalling system in the regulation of developmental patterning. / Int J Dev Biol 2002, plus-plus">46: 375鈥?84.
  4. Klein R: plus-plus">Bidirectional signals establish boundaries. / Curr Biol 1991, plus-plus">9: R691-R694. p://dx.doi.org/10.1016/S0960-9822(99)80441-2">CrossRef
  5. Nakamoto M, Bergemann AD: plus-plus">Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. / Microsc Res Tech 2002, plus-plus">59: 58鈥?7. p://dx.doi.org/10.1002/jemt.10177">CrossRef
  6. Batlle E, Henderson JT, Beghtel H, van den Bron MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H: plus-plus">Beta-Catenin and TCF mediate cell Positioning in the intestinal epithelium by controlling the expression of EphB/ephrin B. / Cell 2002, plus-plus">111: 251鈥?63. p://dx.doi.org/10.1016/S0092-8674(02)01015-2">CrossRef
  7. Sancho E, Batlle E, Clevers H: plus-plus">Live and let die in the intestinal epithelium. / Curr Opin Cell Biol 2003, plus-plus">15: 763鈥?70. p://dx.doi.org/10.1016/j.ceb.2003.10.012">CrossRef
  8. Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, Wang YJ, Song JP, Li ZY, Arai H, Otsuki Y, Kobayashi T, Konno H, Hanai H, Sugimura H: plus-plus">Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. / J Cancer Res Clin Oncol 2002, plus-plus">28: 343鈥?48. p://dx.doi.org/10.1007/s00432-002-0355-0">CrossRef
  9. Stephenson SA, Slomka S, Douglas EL, Hewett PJ, Hardingham JE: plus-plus">Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. / BMC Mol Biol 2001, plus-plus">2: 15. p://dx.doi.org/10.1186/1471-2199-2-15">CrossRef
  10. Berclaz G, Flutsch B, Altermatt HJ, Rohrback H, Djonov V, Ziemiecki A, Dreher E, Andres AC: plus-plus">Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. / Oncol Rep 2002, plus-plus">9: 985鈥?89.
  11. Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A: plus-plus">Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin B2 during mammary gland morphogenesis. / J Cell Sci 1998, plus-plus">111: 2741鈥?1.
  12. Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan F, Bucana CD, Ellis LM: plus-plus">Co-expression of ephrin-Bs and their receptors in colon carcinoma. / Cancer 2002, plus-plus">94: 934鈥?39. p://dx.doi.org/10.1002/cncr.10122">CrossRef
  13. Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F: plus-plus">A novel putative tyrosine kinase receptor encoded by the eph gene. / Science 1987, plus-plus">238: 1717鈥?0. p://dx.doi.org/10.1126/science.2825356">CrossRef
  14. Coulthard MG, Lickliter JD, Subanesan N, Chen K, Webb GC, Lowry AJ, Koblar S, Bottema CD, Boyd AW: plus-plus">Characterisation of the EphA1 receptor tyrosine kinase: expression in epithelial tissues. / Growth Factors 2001, plus-plus">18: 303鈥?17. p://dx.doi.org/10.3109/08977190109029118">CrossRef
  15. Robinson D, He F, Pretlow T, Kung HJ: plus-plus">A tyrosine kinase profile of prostate carcinoma. / Proc Natl Acad Sci USA 1996, plus-plus">93: 5958鈥?2. p://dx.doi.org/10.1073/pnas.93.12.5958">CrossRef
  16. Kao HW, Chen HC, Wu CW, Lin WC: plus-plus">Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids. / Br J Cancer 2003, plus-plus">88: 1058鈥?064. p://dx.doi.org/10.1038/sj.bjc.6600821">CrossRef
  17. Maru Y, Hirai H, Yoshida MC, Takaku F: plus-plus">Evolution, expression and chromosomal location of a novel receptor tyrosine kinase gene, eph. / Molecular & Cellular Biology 1998, plus-plus">8: 3770鈥?.
  18. Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H: plus-plus">EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. / Int J Cancer 2003, plus-plus">103: 657鈥?63. p://dx.doi.org/10.1002/ijc.10860">CrossRef
  19. Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS: plus-plus">EphA2 over-expression causes tumorigenesis of mammary epithelial cells. / Cancer Res 2001, plus-plus">61: 2301鈥?306.
  20. Kinch MS, Moore MB, Harpole DH: plus-plus">Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. / Clin Cancer Res 2003, plus-plus">9: 613鈥?18.
  21. Rosenberg IM, Goke M, Kanai M, Reinecker HC, Podolsky DK: plus-plus">Epithelial cell kinase-B61:an autocrine loop modulating intestinal epithelial migration and barrier function. / Am J Physiol 1997, plus-plus">273: G824-G832.
  22. Dodelet VC, Pasquale EB: plus-plus">Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. / Oncogene 2000, plus-plus">19: 5614鈥?619. p://dx.doi.org/10.1038/sj.onc.1203856">CrossRef
  23. Kullander K, Klein R: plus-plus">Mechanisms and function of eph and ephrin signalling. / Nat Rev Mol Cell Biol 2002, plus-plus">3: 475鈥?86. p://dx.doi.org/10.1038/nrm856">CrossRef
  24. Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z: plus-plus">The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinoma. / Gynecol Oncol 2005, plus-plus">99: 278鈥?6. p://dx.doi.org/10.1016/j.ygyno.2005.06.036">CrossRef
  25. Maru Y, Hirai H, Takaku F: plus-plus">Over-expression confers an oncogenic potential upon the eph gene. / Oncogene 1990, plus-plus">5: 445鈥?.
  26. Easty DJ, Guthrie BA, Maung K, Farr CJ, Lindberg RA, Toso RJ, Herlyn M, Bennett DC: plus-plus">Protein B6 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. / Cancer Research 1995, plus-plus">55: 2528鈥?2.
  27. Straume O, Akslen LA: plus-plus">Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin A1/EphA2 on melanoma progression. / Am J Pathol 2002, plus-plus">160: 1009鈥?019.
  28. Kozlosky CJ, VandenBos T, Park L, Cerretti DP, Carpenter MK: plus-plus">LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain. / Cytokine 1997, plus-plus">9: 540鈥?. p://dx.doi.org/10.1006/cyto.1997.0199">CrossRef
  29. The pre-publication history for this paper can be accessed here:p://www.biomedcentral.com/1471-2407/6/144/prepub" class="a-plus-plus">http://www.biomedcentral.com/1471-2407/6/144/prepub
  
• 作者单位：Nirmitha I Herath (1)
  Mark D Spanevello (1)
  Sabe Sabesan (1)
  Tanya Newton (2)
  Margaret Cummings (4)
  Shannon Duffy (1)
  Douglas Lincoln (3)
  Glen Boyle (2)
  Peter G Parsons (2)
  Andrew W Boyd (1) (4)
  
  1. Leukaemia Foundation Research Unit, University of Queensland, Australia
  2. Melanoma Genomics, University of Queensland, Australia
  4. Faculty of Health Sciences, University of Queensland, Australia
  3. Cancer and Population Studies, Queensland Institute of Medical Research, University of Queensland, Australia
  
• ISSN：1471-2407

文摘

Background Increased expression of Eph receptor tyrosine kinases and their ephrin ligands has been implicated in tumor progression in a number of malignancies. This report describes aberrant expression of these genes in ovarian cancer, the commonest cause of death amongst gynaecological malignancies. Methods Eph and ephrin expression was determined using quantitative real time RT-PCR. Correlation of gene expression was measured using Spearman's rho statistic. Survival was analysed using log-rank analysis and (was visualised by) Kaplan-Meier survival curves. Results Greater than 10 fold over-expression of EphA1 and a more modest over-expression of EphA2 were observed in partially overlapping subsets of tumors. Over-expression of EphA1 strongly correlated (r = 0.801; p < 0.01) with the high affinity ligand ephrin A1. A similar trend was observed between EphA2 and ephrin A1 (r = 0.387; p = 0.06). A striking correlation of both ephrin A1 and ephrin A5 expression with poor survival (r = -0.470; p = 0.02 and r = -0.562; p < 0.01) was observed. Intriguingly, there was no correlation between survival and other clinical parameters or Eph expression. Conclusion These data imply that increased levels of ephrins A1 and A5 in the presence of high expression of Ephs A1 and A2 lead to a more aggressive tumor phenotype. The known functions of Eph/ephrin signalling in cell de-adhesion and movement may explain the observed correlation of ephrin expression with poor prognosis.